Posts by: Catarina Silva, MSc

Catarina Silva, MSc

With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.

April 23, 2018April 23, 2018

#AAN2018 – Early Data Supports Golodirsen in DMD Patients Amenable to Exon 53 Skipping

News

A potential next-generation therapy, golodirsen (SRP-4053) facilitates and increases dystrophin production in Duchenne muscular dystrophy (DMD) patients, an interim analysis of a Phase 1/2 trial being presented at the 2018 American ... Read more

February 26, 2018June 21, 2019

Stem Cell Therapy Improved Duchenne MD Patients’ Heart Disease, Study Shows

News

A stem cell therapy improved the heart function, walking capacity and survival of mice with Duchenne muscular dystrophy, a study reports. The treatment involves what scientists call cardiosphere-derived cells, or ... Read more

December 11, 2017December 11, 2017

Long-term Glucocorticoid Therapy in Duchenne Cuts Death Risk by 50% or More, Study Suggests

News

Researchers found that giving Duchenne muscular dystrophy (DMD) patients glucocorticoid therapy keeps them mobile for a longer period of time and reduces their risk of dying. Their study, “Long-term ... Read more

November 17, 2017November 17, 2017

Muscular Dystrophy Association Awards 13 Research Grants Totaling $3.5 Million

News

•The Muscular Dystrophy Association has awarded 13 grants totaling $3.5 million to researchers working on treatments for neuromuscular diseases such as MD and ALS, studies that identify the diseases’ causes, ... Read more

November 16, 2017November 16, 2017

Molecules Identified That Target Gene Known to Cause FSHD in Study

News

Research into molecules that appear to target the gene known to cause facioscapulohumeral dystrophy (FSHD) may lead to a treatment able to slow disease progression, a study reports. The ... Read more

Pin It on Pinterest